Consecutive evaluation of immunoglobulin M and G antibodies against hepatitis E virus

被引:28
|
作者
Ke, WM
Tan, D
Li, JG
Izumi, S
Shinji, Y
Hotta, H
Yao, JL
机构
[1] Department of Infectious Diseases, Third Affil. Hospitol Sun Yat-Sen U., Shipai, Guangzhou
[2] Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda
[3] Health Development Section, Sumitomo Bank, Osaka
[4] Department of Internal Medicine, Hyogo Pref. Nishinomiya Hospital, Hyogo
[5] Department of Microbiology, Kobe University, School of Medicine, Hyogo
关键词
hepatitis E virus; IgM and IgG anti-HEV; ELISA;
D O I
10.1007/BF02358608
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis E virus (HEV) infection is sporadic in the Guangzhou city southern China, However, the evaluation of antibodies to HEV during consecutive time periods after infection has not been reported. We utilized enzyme immunosorbent assay (ELISA) to detect IgM and IgG anti-HEV in consecutive serum specimens from patients with acute hepatitis E and compared that data with detection rates of IgM and IgG anti-HAV in patients with acute hepatitis A. IgM anti-HEV can be detected as early as 4 days after onset of disease symptoms in some patients. The detection rate of IgM anti-HEV is significantly higher in specimens collected within 4 weeks (95%) of onset than in those specimens collected 4 to 18 weeks after onset (67.6%) (P < 0.005). IgM anti-HEV had a similar pattern to IgM anti-HAV and can be used as a marker of acute HEV infection. In contrast with IgG anti-HAV, 56.8% of the specimens did not contain detectable levels of IgG anti-HEV (P < 0.005). One-should be cautioned against making a diagnosis of HEV infection solely by the currently available assays for IgG anti-HEV. In conclusion, IgM anti-HEV can be used as a reliable and sensitive marker for recent HEV infection, but serum specimens should be collected within 4 weeks after onset of symptoms to avoid false-negative results. In contrast, we should be aware of the failure to develop IgG anti-HEV in some patients. These patients carry the risk of reinfection.
引用
收藏
页码:818 / 822
页数:5
相关论文
共 50 条
  • [31] Hepatitis G virus in intravenous immunoglobulin - Reply
    Healey, CJ
    Chapel, H
    Simmonds, P
    Chapman, RWG
    GASTROENTEROLOGY, 1996, 111 (05) : 1399 - 1400
  • [32] Evaluation of molnupiravir as an antiviral against hepatitis E virus infection
    Sridhar, Siddharth
    Wu, Shusheng
    Situ, Jianwen
    Shun, Estie Hon-Kiu
    Chew, Nicholas Foo-Siong
    JOURNAL OF HEPATOLOGY, 2024, 80 : S757 - S757
  • [33] Infection with hepatitis G virus in immunoglobulin recipients
    Vento, S
    Renzini, C
    Casali, F
    Ferraro, T
    Concia, E
    LANCET, 1997, 349 (9046): : 206 - 207
  • [34] COMPARISON OF SPECIFIC IMMUNOGLOBULIN-G, M AND AGGLUTINATING ANTIBODIES AGAINST LEGIONELLA PNEUMOPHILA
    HARTIGAN, DA
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1981, 13 (04) : 269 - 272
  • [35] Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
    Xu, Xin
    Sun, Jian
    Nie, Sheng
    Li, Huiyuan
    Kong, Yaozhong
    Liang, Min
    Hou, Jinlin
    Huang, Xianzhong
    Li, Dongfeng
    Ma, Tean
    Peng, Jiaqing
    Gao, Shikui
    Shao, Yong
    Zhu, Hong
    Lau, Johnson Yiu-Nam
    Wang, Guangyu
    Xie, Chunbao
    Jiang, Li
    Huang, Ailong
    Yang, Zhenglin
    Zhang, Kang
    Hou, Fan Fan
    NATURE MEDICINE, 2020, 26 (08) : 1193 - +
  • [36] Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
    Xin Xu
    Jian Sun
    Sheng Nie
    Huiyuan Li
    Yaozhong Kong
    Min Liang
    Jinlin Hou
    Xianzhong Huang
    Dongfeng Li
    Tean Ma
    Jiaqing Peng
    Shikui Gao
    Yong Shao
    Hong Zhu
    Johnson Yiu-Nam Lau
    Guangyu Wang
    Chunbao Xie
    Li Jiang
    Ailong Huang
    Zhenglin Yang
    Kang Zhang
    Fan Fan Hou
    Nature Medicine, 2020, 26 : 1193 - 1195
  • [37] Hepatitis G virus RNA and hepatitis G virus E2 antibodies in Dutch hemophilia patients in relation to transfusion history
    Mauser-Bunschoten, EP
    Damen, M
    Zaaijer, HL
    Sjerps, M
    Roosendaal, G
    Lelie, PN
    Cuypers, HTM
    van den Berg, HM
    BLOOD, 1998, 92 (06) : 2164 - 2168
  • [38] Development of a blocking ELISA for detection of antibodies against avian hepatitis E virus
    Liu, Baoyuan
    Zhao, Qin
    Sun, Yani
    Wang, Xinjie
    Zhao, Jinan
    Du, Taofeng
    Wang, Chengbao
    Xiao, Shuqi
    Mu, Yang
    Zhang, Gaiping
    Luo, Jianxuri
    Hsu, Walter H.
    Zhou, En-Min
    JOURNAL OF VIROLOGICAL METHODS, 2014, 204 : 1 - 5
  • [39] The prevalence of antibodies against Hepatitis E Virus in the Czech Republic: serological survey
    Nemecek, V
    Butovicova, P.
    Maly, M.
    Dite, P.
    Vertatova, M.
    Vodickova, I
    Kriz, B.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2017, 66 (01): : 3 - 7
  • [40] SOLID-PHASE RADIOIMMUNOASSAY OF RUBELLA-VIRUS IMMUNOGLOBULIN-G AND IMMUNOGLOBULIN-M ANTIBODIES
    KALIMO, KOK
    MEURMAN, OH
    HALONEN, PE
    ZIOLA, BR
    VILJANEN, MK
    GRANFORS, K
    TOIVANEN, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1976, 4 (02) : 117 - 123